APONTIS PHARM. AG INH ON/ DE000A3CMGM5 /
2024-10-31 5:36:14 PM | Chg. +0.040 | Volume | Bid2024-10-31 | Ask5:36:14 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
9.760EUR | +0.41% | 35,488 Turnover: 343,523.700 |
-Bid Size: - | -Ask Size: - | 81.6 mill.EUR | 0.00% | - |
Assets
|
2021 HGB in mill. EUR |
||
---|---|---|---|
Property and Equipment | .0200 | ||
Intangible Assets | 14.7000 | ||
Long-Term Investments | .8000 | ||
Fixed Assets | - | ||
Inventories | 4.6000 | ||
Accounts Receivable | 2.9000 | ||
Cash and Cash Equivalents | 29.8000 | ||
Current Assets | 38 | ||
Total Assets | 54.1000 |
Liabilities
|
2021 HGB in mill. EUR |
||
---|---|---|---|
Accounts Payable | - | ||
Long-term debt | - | ||
Liabilities to Banks | - | ||
Provisions | - | ||
Liabilities | 12.7000 | ||
Share Capital | 8.5000 | ||
Total Equity | 40.7000 | ||
Minority Interests | - | ||
Total liabilities equity | 54.1000 |
Income Statement
|
2021 HGB in mill. EUR |
||
---|---|---|---|
Revenues | 51.2000 | ||
Depreciation (total) | 1.7000 | ||
Operating Result | 10.4000 | ||
Interest Income | -.4000 | ||
Income Before Taxes | 1.3000 | ||
Income Taxes | .7000 | ||
Minority Interests Profit | - | ||
Net Income | 1 |
Per Share
Cash Flow
|
2021 HGB in mill. EUR |
||
---|---|---|---|
Cash Flow from Operating Activities | 3.4000 | ||
Cash Flow from Investing Activities | -1.8000 | ||
Cash Flow from Financing | 20.1000 | ||
Decrease / Increase in Cash | 21.8000 | ||
Employees | 176 |